NEW YORK, June 27 (GenomeWeb News) - CombiMatrix said today that it has entered into a manufacturing and distribution agreement with Korean biotechnology firm Macrogen.
Specifically, Macrogen will use CombiMatrix CustomArray Synthesizers to develop and sell CustomArrays into Korea, and to offer other services based on the arrays, CombiMatrix said.
Seoul-based Macrogen's core businesses include DNA sequence analysis, biochip manufacture and research, and production of genetically engineered mice. It is also one of 11 worldwide members of Applied Biosystems' Advanced Gene Expression Service Provider Program.
CombiMatrix said that the deal underscores its strategy of establishing manufacturing and distribution relationships with regional companies to enable them to manufacture arrays onsite for their local markets.
Financial details were not disclosed.